These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 918459)

  • 1. [Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy].
    Escourolle R; Bourdon R; Galli A; Galle P; Jaudon MC; Hauw JJ; Gray F
    Rev Neurol (Paris); 1977 Mar; 133(3):153-63. PubMed ID: 918459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
    Buge A; Escourolle R; Poisson M; Gray F; Bleibel JM; Jaudon MC
    Nouv Presse Med; 1979 Mar; 8(13):1071-4. PubMed ID: 461135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The intracerebral distribution of bismuth in bismuth encephalopathy. Pathological and toxicological study of 3 cases (author's transl)].
    Ribadeau Dumas JL; Lechevalier B; Breteau M; Allain Y
    Nouv Presse Med; 1978 Dec; 7(44):4021-5. PubMed ID: 733570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a murine model for human bismuth encephalopathy.
    Ross JF; Sahenk Z; Hyser C; Mendell JR; Alden CL
    Neurotoxicology; 1988; 9(4):581-6. PubMed ID: 3244442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bismuth encephalopathy].
    Krüger G
    Fortschr Neurol Psychiatr; 1984 Jan; 52(1):24-31. PubMed ID: 6698481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between the course of bismuth encephalopathy and the amount of bismuth in blood and urine].
    Boiteau HL; Cler JM; Mathé JF; Delobel R; Fève J
    Eur J Toxicol Environ Hyg; 1976; 9(4):233-9. PubMed ID: 976332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apropos of the 18th case of bismuth encephalopathy recognized in Belgium].
    Lotstra F; Soebert A; Linkowski P; Mendlewicz J
    Acta Neurol Belg; 1983; 83(3):135-41. PubMed ID: 6613516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteoarticular complications in bismuth encephalopathy.
    Emile J; De Bray JM; Bernat M; Morer T; Allain P
    Clin Toxicol; 1981 Nov; 18(11):1285-90. PubMed ID: 7341054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Letter: Bismuth encephalopathy. 4 cases observed in a general medical department].
    Aimez P; Bigorie B; Bour H; Gazengel J; Guy-Grand B
    Nouv Presse Med; 1975 May; 4(20):1505. PubMed ID: 1215151
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reversible encephalopathies caused by bismuth salts. 5 further cases].
    Lhermitte F; Degos CF; Signoret JL
    Nouv Presse Med; 1975 Feb; 4(6):419-20. PubMed ID: 1129094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tomodensitometric aspects of 3 cases of acute bismuth encephalopathy (author's transl)].
    Metzger J; Buge A; Rancurel G; Gardeur D
    Rev Neurol (Paris); 1978 Oct; 134(10):619-24. PubMed ID: 749121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric aspects of encephalopathy caused by bismuth salts].
    Bertaud M; Mangin P; Charlin A
    Ann Med Psychol (Paris); 1976 May; 1(5):717-21. PubMed ID: 970827
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
    Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myoclonic encephalopathy due to bismuth salts. Negative search for an associated toxic element].
    Grandjean EM; Ducommun E; Gauthier G; Courvoisier B
    Schweiz Med Wochenschr; 1976 Jul; 106(30):1006-11. PubMed ID: 996522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Letter: Encephalopathies during treatment with bismuth or the mishaps of"conjugated" bismuth therapy].
    Raverdy P; Smagghe A; Marie JP; Prinseau J
    Nouv Presse Med; 1975 Apr; 4(14):1050. PubMed ID: 805409
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bismuth encephalopathy. Presentation of a case].
    Fernández Barreiro A; Sicilia Guillén J; Castejón Vera P; Escribano Soriano JB; Bautista Prados JG; Díaz Ortuño A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1983; 11(2):127-32. PubMed ID: 6880891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bismuth encephalopathy. A propos of 2 cases].
    Loutre JC; Viguié R; Kunstler E; Nehlil J
    Rev Neurol (Paris); 1975 Dec; 131(12):883-6. PubMed ID: 1232663
    [No Abstract]   [Full Text] [Related]  

  • 20. [Letter: Bismuth induced encephalopathy in a pregnant woman].
    Quereux C; Ezes H; Wahl P; Morice J; Level G
    Nouv Presse Med; 1975 Sep; 4(31):2275. PubMed ID: 1178500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.